目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Clinical Practice
1.2.3. Therapeutic Area
1.2.4. End User
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Clinical practice outlook
2.2.3. Therapeutic Area Outlook
2.2.4. End User outlook
2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Digital Biomarker Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Digital Biomarker Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis

Chapter 4. Digital Biomarker Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Digital Biomarker Market Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Wearable
4.4.1.1. Wearable market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Mobile based applications
4.4.2.1. Mobile based applications market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Sensors
4.4.3.1. Sensors market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Digital Biomarker Market: Clinical Practice Estimates & Trend Analysis
5.1. Clinical Practice Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Digital Biomarker Market Clinical Practice Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Diagnostic digital biomarkers
5.4.1.1. Diagnostic digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Monitoring digital biomarkers
5.4.2.1. Monitoring digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Predictive and Prognostic digital biomarkers
5.4.3.1. Predictive and Prognostic digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Others (Safety, Pharmacodynamics/ Response, Susceptibility)
5.4.4.1. Others (Safety, Pharmacodynamics/ Response, Susceptibility) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Digital Biomarker Market: Therapeutic Area Estimates & Trend Analysis
6.1. Therapeutic Area Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Digital Biomarker Market by Therapeutic Area Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Cardiovascular and metabolic disorders (CVMD)
6.4.1.1. Cardiovascular and metabolic disorders (CVMD) market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Respiratory diseases
6.4.2.1. Respiratory diseases market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Psychiatric disorders
6.4.3.1. Psychiatric disorders market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Sleep & movement disease
6.4.4.1. Sleep & movement disease market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Neurological disorders
6.4.5.1. Neurological disorders market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Musculoskeletal disorders
6.4.6.1. Musculoskeletal disorders market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Others (Diabetes, Pain Management)
6.4.7.1. Others (Diabetes, Pain Management) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Digital Biomarker Market: End User Estimates & Trend Analysis
7.1. End User Type Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Digital Biomarker Market by End User Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Healthcare companies
7.4.1.1. Healthcare companies market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Healthcare Providers
7.4.2.1. Healthcare Providers market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Healthcare Providers
7.4.3.1. Healthcare Providers market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Others (Patient, caregivers)
7.4.4.1. Others (Patient, caregivers) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Digital Biomarker Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. North America: SWOT Analysis
8.5.2. U.S.
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Canada
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Mexico
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. Europe: SWOT Analysis
8.6.2. UK
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. Germany
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. France
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Spain
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Norway
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Sweden
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework
8.6.8.3. Competitive scenario
8.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.9. Denmark
8.6.9.1. Key country dynamics
8.6.9.2. Regulatory framework
8.6.9.3. Competitive scenario
8.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Asia Pacific: SWOT Analysis
8.7.2. Japan
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. China
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. India
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework
8.7.4.3. Competitive scenario
8.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. Australia
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework
8.7.5.3. Competitive scenario
8.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. South Korea
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework
8.7.6.3. Competitive scenario
8.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.7. Thailand
8.7.7.1. Key country dynamics
8.7.7.2. Regulatory framework
8.7.7.3. Competitive scenario
8.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Latin America: SWOT Analysis
8.8.2. Brazil
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Argentina
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. MEA: SWOT Analysis
8.9.2. South Africa
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework
8.9.2.3. Competitive scenario
8.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework
8.9.3.3. Competitive scenario
8.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework
8.9.4.3. Competitive scenario
8.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key country dynamics
8.9.5.2. Regulatory framework
8.9.5.3. Competitive scenario
8.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. Company Market Position Analysis, 2023
9.3.2. ActiGraph LLC
9.3.2.1. Company overview
9.3.2.2. Financial performance
9.3.2.3. Product benchmarking
9.3.2.4. Strategic initiatives
9.3.3. AliveCor Inc.
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Product benchmarking
9.3.3.4. Strategic initiatives
9.3.4. Koneksa
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Altoida Inc.
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Amgen Inc.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Biogen Inc.
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Empatica Inc.
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Vivo Sense
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. IXICO plc
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Adherium Limited
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Vivo Sense
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Neurotrack Technologies, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
9.3.14. Aural Analytic
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Product benchmarking
9.3.14.4. Strategic initiatives
9.3.15. Huma Therapeutics
9.3.15.1. Company overview
9.3.15.2. Financial performance
9.3.15.3. Product benchmarking
9.3.15.4. Strategic initiatives
9.3.16. Sonde Health, Inc.
9.3.16.1. Company overview
9.3.16.2. Financial performance
9.3.16.3. Product benchmarking
9.3.16.4. Strategic initiatives
9.3.17. Clario
9.3.17.1. Company overview
9.3.17.2. Financial performance
9.3.17.3. Product benchmarking
9.3.17.4. Strategic initiatives
9.3.18. Imagene AI
9.3.18.1. Company overview
9.3.18.2. Financial performance
9.3.18.3. Product benchmarking
9.3.18.4. Strategic initiatives
9.3.19. Brainomix
9.3.19.1. Company overview
9.3.19.2. Financial performance
9.3.19.3. Product benchmarking
9.3.19.4. Strategic initiatives
9.3.20. Kinsa Inc.
9.3.20.1. Company overview
9.3.20.2. Financial performance
9.3.20.3. Product benchmarking
9.3.20.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America digital biomarkers market, by region, 2018 - 2030 (USD Million)
Table 4 North America digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 5 North America digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 6 North America digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 7 North America digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 8 U.S digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 9 U.S digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 10 U.S digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 11 U.S digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 12 Canada digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 13 Canada digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 14 Canada digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 15 Canada digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 12 Mexico digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 14 Mexico digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 15 Mexico digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 16 Europe digital biomarkers market, by region, 2018 - 2030 (USD Million)
Table 17 Europe digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 18 Europe digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 19 Europe digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 20 Europe digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 21 U.K digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 22 U.K digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 23 U.K digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 24 U.K digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 21 France digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 22 France digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 23 France digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 24 France digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 25 Germany digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 26 Germany digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 27 Germany digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 28 Germany digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 29 Denmark digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 30 Denmark digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 31 Denmark digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 32 Denmark digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 33 Italy digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 34 Italy digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 35 Italy digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 36 Italy digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 37 Sweden digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 38 Sweden digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 39 Sweden digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 40 Sweden digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific digital biomarkers market, by region, 2018 - 2030 (USD Million)
Table 42 Asia Pacific digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 44 Asia Pacific digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 45 Asia Pacific digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 46 China digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 47 China digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 48 China digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 49 China digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 50 Japan digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 51 Japan digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 52 Japan digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 53 Japan digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 54 India digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 55 India digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 56 India digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 57 India digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 58 Australia digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 59 Australia digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 60 Australia digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 61 Australia digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 62 South Korea digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 63 South Korea digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 64 South Korea digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 65 South Korea digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 66 Latin America digital biomarkers market, by region, 2018 - 2030 (USD Million)
Table 67 Latin America digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 68 Latin America digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 69 Latin America digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 70 Latin America digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 71 Brazil digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 72 Brazil digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 73 Brazil digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 74 Brazil digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 71 Argentina digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 72 Argentina digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 73 Argentina digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 74 Argentina digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 79 MEA digital biomarkers market, by region, 2018 - 2030 (USD Million)
Table 80 MEA digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 81 MEA digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 82 MEA digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 83 MEA digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 84 South Africa digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 85 South Africa digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 86 South Africa digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 87 South Africa digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia digital biomarkers market, by type, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia digital biomarkers market, by therapeutic area, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
Table 89 UAE digital biomarker market, by type, 2018 - 2030 (USD Million)
Table 90 UAE digital biomarker market, by clinical practice, 2018 - 2030 (USD Million)
Table 91 UAE digital biomarker market, by therapeutic area, 2018 - 2030 (USD Million)
Table 92 UAE digital biomarker market, by end user, 2018 - 2030 (USD Million)
Table 93 Kuwait digital biomarker market, by type, 2018 - 2030 (USD Million)
Table 94 Kuwait digital biomarker market, by clinical practice, 2018 - 2030 (USD Million)
Table 95 Kuwait digital biomarker market, by therapeutic area, 2018 - 2030 (USD Million)
Table 96 Kuwait digital biomarker market, by end user, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Digital Biomarker: market outlook
Fig. 9 Digital Biomarker competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Digital Biomarker driver impact
Fig. 13 Digital Biomarker restraint impact
Fig. 14 Digital Biomarker strategic initiatives analysis
Fig. 16 Digital Biomarkers Market: By Type Movement Analysis
Fig. 17 Wearable market estimates and forecasts, 2018 - 2030
Fig. 18 Mobile based applications market estimates and forecasts, 2018 - 2030
Fig. 19 Sensors market estimates and forecasts, 2018 - 2030
Fig. 20 Others market estimates and forecasts, 2018 - 2030
Fig. 21 Digital Biomarkers Market: By Clinical Practice Movement Analysis
Fig. 22 Diagnostic digital biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Monitoring digital biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Predictive and prognostic digital biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others digital biomarker market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Digital Biomarkers Market: By Therapeutic Area Movement Analysis
Fig. 27 Cardiovascular and metabolic disorders (CVMD) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Respiratory disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Psychiatric disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Sleep & movement disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Neurological disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Musculoskeletal disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Digital Biomarkers Market: By End-Use Movement Analysis
Fig. 35 Healthcare companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Healthcare providers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Payers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 Regional outlook, 2023 & 2030
Fig. 41 North America digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 42 U.S. digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 43 Canada digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 43 Mexico digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 44 Europe digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 45 U.K. digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 45 France digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 46 Germany digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 45 Spain digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 47 Denmark digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 47 Sweden digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 47 Norway digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 48 Italy digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 49 Sweden digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 50 Asia Pacific digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 51 Japan digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 52 China digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 53 India digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 54 South Korea digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 55 Australia digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 56 Latin America digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 57 Brazil digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 58 Argentina digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 59 MEA digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 60 South Africa digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 61 Saudi Arabia digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 62 UAE digital biomarkers market estimates and forecasts, 2018 - 2030
Fig. 63 Kuwait digital biomarkers market estimates and forecasts, 2018 - 2030